SERION -Model ELISA agile -Quantitative Immunoassays for the Detection of Human Antibodies
Sometimes we are confronted with extreme situations that require extraordinary solutions. Our new product line supports in such situations and offers qualitative and quantitative immunoassays for the detection of human antibodies directed against specific antigens of bacteria, viruses, fungi and parasites in serum or plasma. SERION ELISA agile is optimized for a higher test throughout while maintaining the same critical performance and evaluation levels as our renowned product line SERION ELISA classic.
Most popular related searches
sars-cov-2
immune response
spike protein
immunoassay
antigen specificity
antigen specific
vaccination
immune monitoring
- The utilization of the whole spike protein ensures an early and sensitive detection of SARS-CoV-2 IgG
- Quantitative IgG test allows monitoring of immune response after infection or vaccination
- Expression of SARS-CoV-2 IgG antibody activity in standardized BAU/ml possible
- Detection of intrathecally synthezised IgG antibodies for CSF diagnostics
- Excellent correlation of the IgG test with neutralization assays
- Sensitive IgA and IgM antibody detection with high specificity ideal for determination of acute infections as complement to direct pathogen detection
- Quantitative evaluation of IgA antibody activities
- In house produced antigens guarantee reliable and reproducible results
Please find out more about our new SERION ELISA agile SARS-CoV-2 at: